Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Pavlakis

Showing results (41-50 of 294) with videos related to

Pageof 30
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individualsM Rosati, A Valentin, D J Patenaude, et al.
Journal of Virology|September 15, 2005
Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virusEloísa Yuste, Welkin Johnson, George N Pavlakis, et al.
The Journal of Biological Chemistry|November 13, 2001
Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complexTomoshige Kino, Olga Slobodskaya, George N Pavlakis, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell linesS Schwartz, B K Felber, E M Fenyö, et al.
Science (New York, N.Y.)|November 21, 1986
Expression and characterization of the trans-activator of HTLV-III/LAV virusC M Wright, B K Felber, H Paskalis, et al.
Plos One|April 21, 2022
Evaluating the effects of second-dose vaccine-delay policies in European countries: A simulation study based on data from GreecePetros Barmpounakis, Nikolaos Demiris, Ioannis Kontoyiannis, et al.
Journal of Virology|November 1, 1990
Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAsS Schwartz, B K Felber, E M Fenyö, et al.
Journal of Virology|December 1, 1994
Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytesA S Zolotukhin, A Valentin, G N Pavlakis, et al.
Cancer|July 15, 1997
Fatal pulmonary toxicity resulting from treatment with gemcitabineN Pavlakis, D R Bell, M J Millward, et al.
AIDS Research and Human Retroviruses|April 23, 2008
A splenic marginal zone-like peripheral blood CD27+B220- B cell population is preferentially depleted in HIV type 1-infected individualsMatthew Morrow, Antonio Valentin, Richard Little, et al.
Pageof 30

Showing results (41-50 of 294) with videos related to

Sort By:
Pageof 30
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individualsM Rosati, A Valentin, D J Patenaude, et al.
Journal of Virology|September 15, 2005
Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virusEloísa Yuste, Welkin Johnson, George N Pavlakis, et al.
The Journal of Biological Chemistry|November 13, 2001
Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complexTomoshige Kino, Olga Slobodskaya, George N Pavlakis, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell linesS Schwartz, B K Felber, E M Fenyö, et al.
Science (New York, N.Y.)|November 21, 1986
Expression and characterization of the trans-activator of HTLV-III/LAV virusC M Wright, B K Felber, H Paskalis, et al.
Plos One|April 21, 2022
Evaluating the effects of second-dose vaccine-delay policies in European countries: A simulation study based on data from GreecePetros Barmpounakis, Nikolaos Demiris, Ioannis Kontoyiannis, et al.
Journal of Virology|November 1, 1990
Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAsS Schwartz, B K Felber, E M Fenyö, et al.
Journal of Virology|December 1, 1994
Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytesA S Zolotukhin, A Valentin, G N Pavlakis, et al.
Cancer|July 15, 1997
Fatal pulmonary toxicity resulting from treatment with gemcitabineN Pavlakis, D R Bell, M J Millward, et al.
AIDS Research and Human Retroviruses|April 23, 2008
A splenic marginal zone-like peripheral blood CD27+B220- B cell population is preferentially depleted in HIV type 1-infected individualsMatthew Morrow, Antonio Valentin, Richard Little, et al.
Pageof 30